PEAK1 Antikörper (AA 715-881)
Kurzübersicht für PEAK1 Antikörper (AA 715-881) (ABIN7166598)
Target
Alle PEAK1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 715-881
-
Kreuzreaktivität
- Human
-
Aufreinigung
- >95%, Protein G purified
-
Immunogen
- Recombinant Human Pseudopodium-enriched atypical kinase 1 protein (715-881AA)
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Recommended dilution: IHC:1:200-1:500,
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4 -
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- PEAK1 (Pseudopodium-Enriched Atypical Kinase 1 (PEAK1))
-
Andere Bezeichnung
- PEAK1
-
Hintergrund
-
Background: Tyrosine kinase that may play a role in cell spreading and migration on fibronectin. May directly or indirectly affect phosphorylation levels of cytoskeleton-associated proteins MAPK1/ERK and PXN.
Aliases: FLJ21140 antibody, FLJ34483 antibody, KIAA2002 antibody, NKF3 kinase family member antibody, PEAK1 antibody, PEAK1_HUMAN antibody, pseudopodium enriched atypical kinase antibody, Pseudopodium-enriched atypical kinase 1 antibody, SGK269 antibody, Sugen kinase 269 antibody, Tyrosine-protein kinase SgK269 antibody
-
UniProt
- Q9H792
Target
-